Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
D000914:Antibodies, Viral / Q000032:analysis*; D002213:Capsid / Q000276:immunology; D002277:Carcinoma / Q000097:blood / Q000276:immunology* / Q000378:metabolism; D002850:Chromatography, Gel; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007071:Immunoglobulin A, Secretory / Q000032:analysis* / Q000378:metabolism; D007074:Immunoglobulin G / Q000032:analysis; D008213:Lymphocyte Activation; D009303:Nasopharyngeal Neoplasms / Q000097:blood / Q000276:immunology* / Q000378:metabolism; D012463:Saliva / Q000276:immunology*
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G